SARS-CoV-2 mucosal neutralising immunity after vaccination (2024)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00705-3
Publication URI: http://dx.doi.org/10.1016/s1473-3099(23)00705-3
Type: Journal Article/Review
Parent Publication: The Lancet Infectious Diseases
Issue: 1